Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pleural Effusion, Malignant × Thiostrepton × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Pleural Effusion, Malignant 1 Mesothelioma, Malignant 1 Mesothelioma 1

Interventions

talimogene laherparepvec 1 rilotumumab 1 ganitumab 1 camrelizumab 1 Thiostrepton 1 Silver Nitrate 1 Nivolumab 1 Etoposide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

RS Oncology LLC

Phase 1/2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡